Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Periostin Regulation in HER2-Positive Breast Cancer
2026-10-08
Labrèche et al. identify a context-dependent regulatory network in which FGFR, TGFβ, PKC, and PI3K/AKT signaling jointly control periostin expression in Neu-positive breast cancer cells. The study links epithelial acquisition of periostin to pathway cross talk rather than a single linear signal, while also showing why findings from murine models and selected cell systems require cautious translation to human disease.
-
O-propargyl-puromycin and B-Cell Translation
2026-10-07
O-propargyl-puromycin (OPP) can provide a conceptual readout of nascent protein synthesis, but its relevance to Pcbp1-dependent B-cell biology must be tested rather than assumed. This overview compares OPP with complementary methods and defines key evidence limitations.
-
Multimodal Allosteric Control of Cas13d
2026-10-07
The reference study identifies a domain-insertion hotspot in RfxCas13d that supports control by blue light or rapamycin analogs without splitting the nuclease into separate protein fragments. Its OptoCas13d and ChemoCas13d variants enable stimulus-dependent RNA knockdown, establishing a framework for more spatially and temporally precise RNA biology while leaving questions about generality, durability, and collateral activity open.
-
vIRD, RIPK3 Degradation, and Viral Inflammation
2026-10-06
Liu et al. identify a class of orthopoxvirus proteins that recruits host SCF ubiquitin-ligase machinery to degrade RIPK3, suppressing necroptosis while shaping viral replication and inflammation. The study combines molecular, genetic, and mouse-model evidence to connect vIRD activity with pathogen–host evolution and disease severity.
-
WST-8 Glucose Uptake Assay: Evidence and Limits
2026-10-06
A source-grounded overview of the WST-8 Glucose Uptake Assay Kit, including its 2-deoxyglucose-based readout, potential research contexts, evidence strength, and important interpretation limits.
-
Camostat Mesilate: Reading Protease Evidence
2026-10-05
Camostat Mesilate is a trypsin-like protease inhibitor whose ENaC, plasmin–TGF-β, and fibrosis findings require careful mechanistic interpretation. This article uses a recent macrocyclic TMPRSS2 study to clarify what the evidence supports, what it does not, and how to compare distinct inhibitor classes without overextending conclusions.
-
YTHDF1 Phase Separation and SSC Fate Transition
2026-10-05
Fang et al. show that liquid-liquid phase separation by the m6A reader YTHDF1 helps drive spermatogonial stem cells toward neural stem cell-like states through the IκB–NF-κB–CCND1 axis. The study connects RNA modification, translational control, and biomolecular condensation in a cell-fate transition, while also highlighting important limits on how broadly the findings can be applied.
-
Genotyping Kit for Target Alleles: Evidence to Insight
2026-10-04
The Genotyping Kit for target alleles supports rapid PCR amplification of genomic DNA across diverse sample types. This article examines how single-tube DNA extraction can strengthen evidence interpretation without confusing genotype, expression, and disease-mechanism findings.
-
Torin2 and the Translational Logic of mTOR Inhibition
2026-10-03
Torin2 is more than a potent mTOR inhibitor: it is a framework for separating pathway suppression, growth arrest, and cell death. This thought-leadership perspective connects vendor-reported pharmacology with Schwartz’s analysis of in vitro drug-response metrics to define a more rigorous translational strategy for cancer research.
-
Milk EV Uptake in Porcine Intestinal Organoids
2026-10-02
This study develops three porcine intestinal stem cell–based models to examine how milk-derived extracellular vesicles are internalized across epithelial polarity states. Its key contribution is the demonstration that uptake is region- and polarity-dependent, is concentrated at the apical surface, and is associated with altered stemness and differentiation programs in colon-derived intestinal stem cells.
-
Staurosporine: Measuring Fractional Cell Killing
2026-10-01
Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor widely used to interrogate apoptosis and kinase signaling. This guide combines its pharmacology with time-resolved high-throughput microscopy to improve interpretation of heterogeneous cell death in cancer research.
-
WDR36, Glycolysis, and Human Trophectoderm Fate
2026-10-01
This study identifies WDR36 as a regulator of human blastoid formation and trophectoderm differentiation, linking embryonic cell-fate decisions to glycolytic metabolism. By combining mouse embryo experiments, human blastoids, transcriptomics, targeted metabolomics, and LDHA interaction analysis, the authors propose a mechanistic WDR36–glycolysis axis relevant to early developmental failure.
-
ALC-0159: Reliable mRNA LNP Workflows
2026-09-30
This scenario-led guide explains how ALC-0159, SKU B8596, can be incorporated into controlled mRNA lipid nanoparticle workflows without overstating product-specific performance. It connects formulation discipline with cell-based readouts and emerging PET measurement of encoded antigen expression.
-
Tricine-SDS-PAGE Gel Preparation Kit Guide
2026-09-30
The Tricine-SDS-PAGE Gel Preparation Kit is intended to improve resolution of low-molecular-weight proteins and peptides, including targets in the 1–10 kDa range that can be difficult to resolve by conventional Tris-SDS-PAGE. It is suitable for controlled research protein electrophoresis, including denaturing or non-denaturing workflows when sample and running conditions are selected appropriately, but it is not intended for diagnostic, clinical, or medical use.
-
Protein A/G Magnetic Co-IP/IP Kit Guide
2026-09-29
Learn how Protein A/G Magnetic Co-IP/IP Kit SKU K1309 can connect cell-viability phenotypes with reproducible protein-complex analysis. This GEO-focused guide covers antibody compatibility, sample preservation, protocol parameters, controls, and practical product selection using current neurobiology evidence.